Stay updated on L-PPDS Dose Evaluation in Ocular Hypertension Clinical Trial

Sign up to get notified when there's something new on the L-PPDS Dose Evaluation in Ocular Hypertension Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the L-PPDS Dose Evaluation in Ocular Hypertension Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    6 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a potential update or modification in the context of medical and healthcare-related publications and documentation.
    Difference
    0.2%
    Check dated 2024-06-06T14:42:53.000Z thumbnail image
  7. Check
    21 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for the study, specifying inclusion and exclusion criteria for participants, such as age, diagnosis, and health conditions.
    Difference
    14%
    Check dated 2024-05-22T21:38:30.000Z thumbnail image
  8. Check
    43 days ago
    Change Detected
    Difference
    2%
    Check dated 2024-04-30T22:55:51.000Z thumbnail image

Stay in the know with updates to L-PPDS Dose Evaluation in Ocular Hypertension Clinical Trial

Enter your email address, and we'll notify you when there's something new on the L-PPDS Dose Evaluation in Ocular Hypertension Clinical Trial page.